CD99 and acute myeloid leukemia: Immunophenotypic analysis of the myeloid lineage markers CD13 and CD33, monocyte differentiation marker CD14, and AML stem/progenitor markers CD34, CD38, CD97, CD99, and CD123 was performed in emetine-treated KG-1a cells after 48 h (Fig. 2A–H).